PET and optical imaging of caveolin-1 in gastric tumors Journal Article


Authors: Panikar, S. S.; Shmuel, S.; Lewis, J. S.; Pereira, P. M. R.
Article Title: PET and optical imaging of caveolin-1 in gastric tumors
Abstract: Previous studies have suggested tumoral caveolin-1 (CAV1) as a predictive biomarker for the response to anti-HER2 antibody drug therapies in gastric tumors. In this study, radiolabeled and fluorescently labeled anti-CAV1 antibodies were developed and tested as an immunoPET or optical imaging agent to detect CAV1 in HER2-positive/CAV1-high NCIN87 gastric tumors. The expression of CAV1 receptors in NCIN87 gastric tumors and nontumor murine organs was determined by Western blot. Binding assays were performed to validate the anti-CAV1 antibody specificity for CAV1-expressing NCIN87 cancer cells. Subcutaneous and orthotopic NCIN87 xenografts were used for PET imaging and ex vivo biodistribution of the radioimmunoconjugate. Additional HER2-PET and CAV1-optical imaging was also performed to determine CAV1 in the HER2-positive tumors. Zr-89-labeled anti-CAV1 antibody was able to bind to CAV1-expressing NCIN87 cells with a B(max )value of 2.7 x 10(3) CAV1 receptors/cell in vitro. ImmunoPET images demonstrated the localization of the antibody in subcutaneous NCIN87 xenografts. In the orthotopic model, CAV1 expression was also observed by optical imaging in the HER2-positive tumors previously imaged with HER2-PET. Ex vivo biodistribution analysis further confirmed these imaging results. The preclinical data from this study demonstrate the potential of using CAV1-PET and optical imaging for detecting gastric tumors.
Keywords: down-regulation; carcinoma; breast-cancer; expression
Journal Title: ACS Omega
Volume: 8
Issue: 39
ISSN: 2470-1343
Publisher: American Chemical Society  
Date Published: 2023-10-03
Start Page: 35884
End Page: 35892
Language: English
ACCESSION: WOS:001068500600001
DOI: 10.1021/acsomega.3c03614
PROVIDER: wos
PMCID: PMC10552508
PUBMED: 37810678
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason S Lewis
    456 Lewis